natgillin/translations-raw huggingface dataset:
It is therefore necessary to allocate to other Member States the evaluation of the active substances for which the United Kingdom is the rapporteur Member State and where a decision on their renewal of approval is not expected before 30 March 2019.
Ako taj sporazum stupi na snagu, zakonodavstvo Unije u području sredstava za zaštitu bilja primjenjivat će se u skladu s tim sporazumom na Ujedinjenu Kraljevinu i u Ujedinjenoj Kraljevini tijekom prijelaznog razdoblja te će se prestati primjenjivati nakon isteka tog razdoblja.
The active substances concerned are 1-methylcyclopropene, famoxadone, mancozeb, methiocarb, methoxyfenozide, pirimicarb, pirimiphos-methyl and thiacloprid.
Međutim, čak i ako EU i Ujedinjena Kraljevina ratificiraju Sporazum o povlačenju, tijekom prijelaznog razdoblja Ujedinjena Kraljevina ne smije djelovati kao vodeće tijelo za procjene rizika, ispitivanja, odobrenja ili ovlaštenja na razini Unije ili na razini država članica koje djeluju zajednički, kako je navedeno, među ostalim, u Uredbi (EZ) br. 1107/2009.
That allocation should ensure a balance in the distribution of the responsibilities and the work between Member States.
Stoga je potrebno drugim državama članicama dodijeliti ocjenu aktivnih tvari za koje je Ujedinjena Kraljevina država članica izvjestiteljica te ako se odluka o produljenju odobrenja tih tvari ne očekuje prije 30. ožujka 2019.
As the evaluation of the active substances concerned are at an advanced stage and the work to be carried out is expected to be minor, a co-rapporteur Member State should not be allocated for that evaluation.
Riječ je o aktivnim tvarima 1-metilciklopropen, famoksadon, mankozeb, metiokarb, metoksifenozid, pirimikarb, pirimifos-metil i tiakloprid.
Implementing Regulation (EU) No 686/2012 and Regulation (EU) No 1141/2010 should therefore be amended accordingly.
Tom bi se dodjelom trebala osigurati ravnoteža u raspodjeli odgovornosti i posla među državama članicama.
However, in case the two year period referred to in Article 50(3) of the Treaty on European Union is extended, this Regulation should apply from the day following that on which legislation in the field of plant protection products ceases to apply to and in the United Kingdom, as, in accordance with Article 4(3) of Council Regulation (EEC, Euratom) No 1182/71, the cessation of application of acts fixed at a given date occurs on the expiry of the last hour of the day falling on that date.
Provedbenu uredbu (EU) br. 686/2012 i Uredbu (EU) br. 1141/2010 trebalo bi stoga na odgovarajući način izmijeniti.
Implementing Regulation (EU) No 686/2012 is amended in accordance with Annex I to this Regulation.
Provedbena uredba (EU) br. 686/2012 mijenja se u skladu s Prilogom I. ovoj Uredbi.
Regulation (EU) No 1141/2010 is amended in accordance with Annex II to this Regulation.
Uredba (EU) br. 1141/2010 mijenja se u skladu s Prilogom II. ovoj Uredbi.
It shall apply from 30 March 2019.
Primjenjuje se od 30. ožujka 2019.
However, where a decision has been taken to extend the two year period referred to in Article 50(3) of the Treaty on European Union, this Regulation shall apply from the day following that on which legislation in the field of plant protection products ceases to apply to and in the United Kingdom.
Međutim, ako je donesena odluka o produljenju razdoblja od dvije godine iz članka 50. stavka 3.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Ugovora o Europskoj uniji, ova se Uredba primjenjuje od sljedećeg dana od dana kada se zakonodavstvo u području sredstava za zaštitu bilja prestaje primjenjivati na Ujedinjenu Kraljevinu i u Ujedinjenoj Kraljevini.
Done at Brussels, 27 February 2019.
Ova je Uredba u cijelosti obvezujuća i izravno se primjenjuje u svim državama članicama.
For the Commission
Sastavljeno u Bruxellesu 27. veljače 2019.
Commission Implementing Regulation (EU) No 686/2012 of 26 July 2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of active substances (OJ L 200, 27.7.2012, p. 5).
SL L 309, 24.11.2009., str. 1.
Commission Regulation (EU) No 1141/2010 of 7 December 2010 laying down the procedure for the renewal of the inclusion of a second group of active substances in Annex I to Council Directive 91/414/EEC and establishing the list of those substances (OJ L 322, 8.12.2010, p. 10).
Provedbena uredba Komisije (EU) br. 686/2012 od 26. srpnja 2012. o dodjeljivanju ocjene aktivnih tvari državama članicama radi postupka obnavljanja (SL L 200, 27.7.2012., str. 5.).
Regulation (EEC, Euratom) No 1182/71 of the Council of 3 June 1971 determining the rules applicable to periods, dates and time limits (OJ L 124, 8.6.1971, p. 1).
Uredba Komisije (EU) br. 1141/2010 od 7. prosinca 2010. o utvrđivanju postupka za produljenje uvrštenja druge grupe aktivnih tvari u Prilog I. Direktivi Vijeća 91/414/EEZ i utvrđivanju popisa tih tvari (SL L 322, 8.12.2010., str. 10.).
ANNEX I
Uredba Vijeća (EEZ, Euratom) br. 1182/71 od 3. lipnja 1971. o utvrđivanju pravila koja se primjenjuju na razdoblja, datume i rokove (SL L 124., 8.6.1971., str. 1.).
Part A of the Annex to Implementing Regulation (EU) No 686/2012 is amended as follows:
PRILOG I.
the entry for 1-methyl-cyclopropene is replaced by the following:
Dio A Priloga Provedbenoj uredbi (EU) br. 686/2012 mijenja se kako slijedi:
Active substance
unos za 1-metil-ciklopropen zamjenjuje se sljedećim:
‘1-methyl-cyclopropene
Država članica suizvjestiteljica
the entry for Mancozeb is replaced by the following:
„1-metil-ciklopropen
‘Mancozeb
unos za mankozeb zamjenjuje se sljedećim:
the entry for Methiocarb is replaced by the following:
„Mankozeb
‘Methiocarb
unos za metiokarb zamjenjuje se sljedećim:
the entry for Methoxyfenozide is replaced by the following:
„Metiokarb
‘Methoxyfenozide
unos za metoksifenozid zamjenjuje se sljedećim:
the entry for Pirimicarb is replaced by the following:
„Metoksifenozid
‘Pirimicarb
unos za pirimikarb zamjenjuje se sljedećim:
the entry for Pirimiphos-methyl is replaced by the following:
„Pirimikarb
‘Pirimiphos-methyl
unos za pirimifos-metil zamjenjuje se sljedećim:
the entry for Thiacloprid is replaced by the following:
„Pirimifos-metil
‘Thiacloprid
unos za tiakloprid zamjenjuje se sljedećim:
ANNEX II
„Tiakloprid
In Annex I to Regulation (EU) No 1141/2010, the entry for Famoxadone is replaced by the following:
PRILOG II.
Column A
U Prilogu I. Uredbi (EU) br. 1141/2010 unos za famoksadon zamjenjuje se sljedećim:
Column B
Stupac A
Column C
Stupac B
Column D
Stupac C
‘Famoxadone
Stupac D
31 August 2012’
„Famoksadon
This Regulation should apply from 30 March 2019.
31. kolovoza 2012.”
approving the active substance mefentrifluconazole in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011
o odobravanju aktivne tvari mefentriflukonazol u skladu s Uredbom (EZ) br. 1107/2009 Europskog parlamenta i Vijeća o stavljanju na tržište sredstava za zaštitu bilja te o izmjeni Priloga Provedbenoj uredbi Komisije (EU) br. 540/2011
In accordance with Article 7(1) of Regulation (EC) No 1107/2009, the United Kingdom received on 29 February 2016 an application from BASF Agro B.V. for the approval of the active substance mefentrifluconazole.
U skladu s člankom 7. stavkom 1.
In accordance with Article 9(3) of Regulation (EC) No 1107/2009, the United Kingdom, as rapporteur Member State, notified the applicant, the other Member States, the Commission and the European Food Safety Authority (‘the Authority’) on 30 March 2016 of the admissibility of the application.
Uredbe (EZ) br. 1107/2009 Ujedinjena Kraljevina je 29. veljače 2016. od trgovačkog društva BASF Agro B.V. primila zahtjev za odobrenje aktivne tvari mefentriflukonazol.
On 25 April 2017, the rapporteur Member State submitted a draft assessment report to the Commission with a copy to the Authority, assessing whether that active substance can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009.
U skladu s člankom 9. stavkom 3.
The Authority complied with Article 12(1) of Regulation (EC) No 1107/2009.
Uredbe (EZ) br. 1107/2009 Ujedinjena Kraljevina je kao država članica izvjestiteljica 30. ožujka 2016. obavijestila podnositelja zahtjeva, ostale države članice, Komisiju i Europsku agenciju za sigurnost hrane („Agencija”) o prihvatljivosti zahtjeva.
In accordance with Article 12(3) of Regulation (EC) No 1107/2009, it requested that the applicant supply additional information to the Member States, the Commission and the Authority.
Država članica izvjestiteljica 25. travnja 2017.
The assessment of the additional information by the rapporteur Member State was submitted to the Authority in the format of an updated draft assessment report on 1 February 2018.
Komisiji je dostavila nacrt izvješća o ocjeni, uz kopiju Agenciji, u kojem je ocijenila može li se očekivati da ta aktivna tvar ispunjava mjerila za odobravanje predviđena u članku 4.
On 5 July 2018, the Authority communicated to the applicant, the Member States and the Commission its conclusion on whether the active substance mefentrifluconazole can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009.
Uredbe (EZ) br. 1107/2009.
The Authority made its conclusion available to the public.
Agencija se pridržavala članka 12. stavka 1.
As regards the new criteria to identify endocrine disrupting properties introduced by Commission Regulation (EU) 2018/605, which became applicable on 10 November 2018 and the joint guidance document to identify endocrine disrupting substances, the conclusion of the Authority infers that it is unlikely that mefentrifluconazole is an endocrine disrupter via the estrogenic, androgenic, thyroidogenic and steroidogenic modalities.
Uredbe (EZ) br. 1107/2009.
Furthermore, based on the available evidence and according to the guidance for the identification of endocrine disruptors, mefentrifluconazole is unlikely to be an endocrine disruptor for fish considering that the test modalities have been appropriately covered.
U skladu s člankom 12. stavkom 3.
The Commission therefore considers that mefentrifluconazole is not to be considered as having endocrine disrupting properties.
Uredbe (EZ) br. 1107/2009 zatražila je da podnositelj zahtjeva državama članicama, Komisiji i Agenciji dostavi dodatne informacije.
On 12 December 2018, the Commission presented to the Standing Committee on Plants, Animals, Food and Feed the review report for mefentrifluconazole and on 25 January 2019, it presented a draft Regulation providing that mefentrifluconazole is approved.
Država članica izvjestiteljica dostavila je Agenciji ocjenu dodatnih informacija 1. veljače 2018. u obliku ažuriranog nacrta izvješća o ocjeni.
The applicant was given the possibility to submit comments on the review report.
Agencija je 5. srpnja 2018. podnositelju zahtjeva, državama članicama i Komisiji dostavila zaključak o tome može li se pretpostaviti da aktivna tvar mefentriflukonazol ispunjava mjerila za odobravanje iz članka 4.
It has been established with respect to one or more representative uses of at least one plant protection product containing the active substance, and in particular the uses which were examined and detailed in the review report, that the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009 are satisfied.
Uredbe (EZ) br. 1107/2009.
It is therefore appropriate to approve mefentrifluconazole.
Agencija je svoje zaključke stavila na raspolaganje javnosti.
In accordance with Article 13(2) of Regulation (EC) No 1107/2009 in conjunction with Article 6 thereof and in the light of current scientific and technical knowledge, it is, however, necessary to include certain conditions and restrictions.
S obzirom na nove kriterije za utvrđivanje svojstava endokrine disrupcije uvedene Uredbom Komisije (EU) 2018/605, koja se počela primjenjivati 10. studenoga 2018., i zajedničke smjernice za utvrđivanje endokrino disruptivnih tvari, zaključak je Agencije da je vrlo mala vjerojatnost da je mefentriflukonazol endokrini disruptor s učinkom na rad estrogena, androgena, steroidnih hormona i hormona štitnjače.
It is, in particular, appropriate to require further confirmatory information.
Nadalje, na temelju dostupnih dokaza i u skladu sa smjernicama za utvrđivanje endokrinih disruptora, vrlo je mala vjerojatnost da je mefentriflukonazol endokrini disruptor za ribe, s obzirom na to da su provedene odgovarajuće metode testiranja.
In accordance with Article 13(4) of Regulation (EC) No 1107/2009, the Annex to Commission Implementing Regulation (EU) No 540/2011 should be amended accordingly.
Komisija stoga smatra da se mefentriflukonazol ne treba smatrati tvari sa svojstvima endokrine disrupcije.
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,
Komisija 12. prosinca 2018.
HAS ADOPTED THIS REGULATION:
Stalnom odboru za bilje, životinje, hranu i hranu za životinje dostavila izvješće o pregledu za mefentriflukonazol, a 25. siječnja 2019. nacrt uredbe kojom se predviđa odobravanje mefentriflukonazola.
Article 1
Podnositelju zahtjeva omogućeno je podnošenje primjedbi na izvješće o pregledu.
Approval of active substance
Za jednu ili više reprezentativnih uporaba najmanje jednog sredstva za zaštitu bilja koje sadržava tu aktivnu tvar, a posebno za uporabe koje su ispitane i detaljno opisane u izvješću o pregledu, utvrđeno je da su mjerila za odobravanje predviđena člankom 4.
The active substance mefentrifluconazole, as specified in Annex I, is approved subject to the conditions laid down in that Annex.
Uredbe (EZ) br. 1107/2009 ispunjena.
Article 2
Stoga je primjereno odobriti mefentriflukonazol.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Mjere predviđene u ovoj Uredbi u skladu su s mišljenjem Stalnog odbora za bilje, životinje, hranu i hranu za životinje,
Done at Brussels, 27 February 2019.
DONIJELA JE OVU UREDBU:
OJ L 309, 24.11.2009, p. 1.
Aktivna tvar mefentriflukonazol, kako je utvrđena u Prilogu I., odobrava se u skladu s uvjetima utvrđenima u tom prilogu.
Conclusion on the peer review of the pesticide risk assessment of the active substance BAS 750 F (mefentrifluconazole).
Izmjene Provedbene uredbe (EU) br. 540/2011
EFSA Journal 2018;16(7):5379, 32 pp, https://doi.org/10.2903/j.efsa.2018.5379
Prilog Provedbenoj uredbi (EU) br. 540/2011 mijenja se u skladu s Prilogom II. ovoj Uredbi.
ECHA (European Chemicals Agency) and EFSA (European Food Safety Authority) with the technical support of the Joint Research Centre (JRC), Andersson N, Arena M, Auteri D, Barmaz S, Grignard E, Kienzler A, Lepper P, Lostia AM, Munn S, Parra Morte JM, Pellizzato F, Tarazona J, Terron A and Van der Linden S, 2018.
Stupanje na snagu
Guidance for the identification of endocrine disruptors in the context of Regulations (EU) No 528/2012 and (EC) No 1107/2009.
Ova Uredba stupa na snagu dvadesetog dana od dana objave u Službenom listu Europske unije.
EFSA Journal 2018;16(6):5311, 135 pp. https://doi.org/10.2903/j.efsa.2018.5311.
Ova je Uredba u cijelosti obvezujuća i izravno se primjenjuje u svim državama članicama.
Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances (OJ L 153, 11.6.2011, p. 1).
Sastavljeno u Bruxellesu 27. veljače 2019.
Common Name,
Predsjednik
Identification Numbers
SL L 309, 24.11.2009., str. 1.
IUPAC Name
EFSA Journal 2018.;16(7):5379, 32 str., https://doi.org/10.2903/j.efsa.2018.5379.
Purity
Uredba Komisije (EU) 2018/605 оd 19. travnja 2018. o izmjeni Priloga II.
Date of approval
Uredbi (EZ) br. 1107/2009 utvrđivanjem znanstvenih kriterija za određivanje svojstava endokrine disrupcije (SL L 101, 20.4.2018., str. 33.).
Mefentrifluconazole
Uobičajeni naziv,
CAS No: 1417782-03-6
identifikacijski brojevi
CIPAC No: Not assigned
Kemijski naziv prema IUPAC-u
(2RS)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol
Čistoća
The impurity N, N-dimethylformamide shall not exceed 0,5 g/kg in the technical material.
Datum odobrenja
The impurity toluene shall not exceed 1 g/kg in the technical material
Prestanak odobrenja
The impurity 1,2,4-(1H)-triazole shall not exceed 1 g/kg in the technical material
Posebne odredbe
20 March 2019
Mefentriflukonazol
20 March 2029
CAS br.: 1417782-03-6
For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on mefentrifluconazole, and in particular Appendices I and II thereof, shall be taken into account.
CIPAC br.: nije dodijeljen.
In this overall assessment Member States shall pay particular attention to:
(2RS)-2-[4-(4-klorofenoksi)-2-(trifluorometil)fenil]-1-(1H-1,2,4-triazol-1-il)propan-2-ol
the protection of operators, ensuring that conditions of use include the application of adequate personal protective equipment;
Nečistoća N, N-dimetilformamid ne smije prelaziti 0,5 g/kg u tehničkom materijalu.
the protection of aquatic organisms.
Nečistoća toluen ne smije prelaziti 1 g/kg u tehničkom materijalu.
Conditions of use shall include risk mitigation measures, such as buffer zones and/or vegetative strips, where appropriate.
Nečistoća 1,2,4-(1H)-triazol ne smije prelaziti 1 g/kg u tehničkom materijalu.
The applicant shall submit to the Commission, the Member States and the Authority confirmatory information as regards:
20. ožujka 2019.
the technical specification of the active substance as manufactured (based on commercial scale production) and the compliance of the toxicity batches with the confirmed technical specification;
20. ožujka 2029.
the effect of water treatment processes on the nature of residues present in surface and groundwater, when surface water or ground water is abstracted for drinking water.
Za provedbu jedinstvenih načela iz članka 29. stavka 6.
The applicant shall submit the information referred to in point 1 by 20 March 2020 and the information referred to in point 2 within two years from the date of publication, by the Commission, of a guidance document on evaluation of the effect of water treatment processes on the nature of residues present in surface and groundwater.
Uredbe (EZ) br.
Further details on identity and specification of active substance are provided in the review report.
1107/2009 uzimaju se u obzir zaključci izvješća o pregledu za mefentriflukonazol, a posebice njegovi dodaci I. i II.
ANNEX II
U toj ukupnoj ocjeni države članice moraju obratiti posebnu pozornost na sljedeće:
The applicant shall submit the information referred to in point 1 by 20 March 2020 and the information referred to in point 2 within two years from the date of publication, by the Commission, of a guidance document on evaluation of the effect of water treatment processes on the nature of residues present in surface and groundwater.’
zaštitu vodenih organizama.
EFSA Journal 2018;16(6):5311, 135 pp. https://doi.org/10.2903/j.efsa.2018.5311.
tehničke specifikacije aktivne tvari kako se proizvodi (na temelju komercijalne razine proizvodnje) i sukladnosti serija za ispitivanje toksičnosti s potvrđenom tehničkom specifikacijom;
Jean-Claude Juncker
učinka postupaka pročišćavanja vode na vrstu ostataka prisutnih u površinskim i podzemnim vodama, kada se površinska ili podzemna voda zahvaća za vodu za piće.
of 28 February 2019
оd 28. veljače 2019.
providing derogations from Article 1(3) of Regulation (EC) No 1924/2006 of the European Parliament and of the Council on nutrition and health claims made on food for the use of certain generic descriptors
o predviđanju odstupanja od članka 1. stavka 3.
(Text with EEA relevance)
Uredbe (EZ) br. 1924/2006 Europskog parlamenta i Vijeća o prehrambenim i zdravstvenim tvrdnjama koje se navode na hrani za uporabu određenih generičkih deskriptora
Having regard to Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods, and in particular Article 1(4) thereof,
uzimajući u obzir Ugovor o funkcioniranju Europske unije,
Whereas:
uzimajući u obzir Uredbu (EZ) br. 1924/2006 Europskog parlamenta i Vijeća od 20. prosinca 2006. o prehrambenim i zdravstvenim tvrdnjama koje se navode na hrani, a posebno njezin članak 1. stavak 4.,
Pursuant to Regulation (EC) No 1924/2006, any claim made on food which states, suggests or implies that a relationship exists between a food category, a food or one of its constituents and health is to be considered as a health claim and therefore must comply with that Regulation.
budući da:
Article 1(4) of Regulation (EC) No 1924/2006 provides for a possible derogation from the rules applicable pursuant to Article 1(3) of that Regulation for generic descriptors (denominations) which have traditionally been used to indicate a particularity of a class of foods or beverages which could imply an effect on human health.
U skladu s Uredbom (EZ) br. 1924/2006 svaka tvrdnja navedena na hrani kojom se izjavljuje, sugerira ili naznačuje da postoji odnos između neke kategorije hrane, određene hrane ili jedne od njezinih sastavnica i zdravlja treba se smatrati zdravstvenom tvrdnjom i stoga mora biti u skladu s tom uredbom.
Applications for a term to be used as generic descriptor may be submitted by food business operators to the national competent authority of a recipient Member State.
Člankom 1. stavkom 4.
Pursuant to Commission Regulation (EU) No 907/2013 setting the rules for applications concerning the use of generic descriptors (denominations), a valid application should be transmitted to the Commission and to all Member States; Member States concerned by the application shall provide the Commission with their opinions thereon.
Uredbe (EZ) br. 1924/2006 predviđeno je moguće odstupanje od pravila koja se primjenjuju u skladu s člankom 1. stavkom 3. te uredbe za generičke deskriptore (nazive) koji se već tradicionalno upotrebljavaju za naznačavanje posebnosti određene klase hrane ili pića koja bi mogla imati utjecaja na zdravlje ljudi.
Following receipt of a valid application and the opinions of Member States concerned the Commission may initiate the procedure of approval of the generic descriptor pursuant to Article 1(4) of Regulation (EC) No 1924/2006.
Zahtjevi za uporabu određenog izraza kao generičkog deskriptora subjekti u poslovanju s hranom mogu podnijeti nacionalnom nadležnom tijelu države članice primateljice.
On 13 April 2015, the Austrian competent authority provided the Commission with an application from the Austrian Food Industries' Association, submitted pursuant to Article 1(4) of Regulation (EC) No 1924/2006, for the terms ‘Hustenbonbon’ and ‘Hustenstopper’ to be used as generic descriptors in Austria.
U skladu s Uredbom Komisije (EU) br. 907/2013 o utvrđivanju pravila za zahtjeve o uporabi generičkih deskriptora (naziva), valjani zahtjev trebalo bi proslijediti Komisiji i svim državama članicama; Države članice na koje se odnosi zahtjev Komisiji dostavljaju svoje mišljenje o njemu.
On 13 April 2015, the Austrian competent authority provided the Commission with an application from Drapal GmbH, submitted pursuant to Article 1(4) of Regulation (EC) No 1924/2006, for the term ‘Hustenzuckerl’ to be used as generic descriptor in Austria.
Po primitku valjanog zahtjeva i mišljenja predmetnih država članica Komisija može pokrenuti postupak za odobrenje generičkog deskriptora u skladu s člankom 1. stavkom 4.
On 19 May 2015, the German competent authority provided the Commission with an application from the Association of the German Confectionary Industry, submitted pursuant to Article 1(4) of Regulation (EC) No 1924/2006, for the term ‘Brust-Caramellen’ to be used as generic descriptors in Germany and in Austria.
Uredbe (EZ) br. 1924/2006.